Related references
Note: Only part of the references are listed.Genome-wide analysis discloses reversal of the hypoxia-induced changes of gene expression in colon cancer cells by zinc supplementation
Michal Sheffer et al.
Oncotarget (2015)
RAB8 Enhances TMEM205-Mediated Cisplatin Resistance
Ding-Wu Shen et al.
PHARMACEUTICAL RESEARCH (2012)
HIF-1α in Epidermis: Oxygen Sensing, Cutaneous Angiogenesis, Cancer, and Non-Cancer Disorders
Hamid R. Rezvani et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
A close look at cancer INTRODUCTION
Alison Farrell
NATURE MEDICINE (2011)
Meta-analysis of archived DNA microarrays identifies genes regulated by hypoxia and involved in a metastatic phenotype in cancer cells
Michael Pierre et al.
BMC CANCER (2010)
HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells
Junye Liu et al.
EXPERIMENTAL CELL RESEARCH (2010)
Elevated Expression of TMEM205, a Hypothetical Membrane Protein, Is Associated With Cisplatin Resistance
Ding-Wu Shen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia
Lionel Flamant et al.
MOLECULAR CANCER (2010)
Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-κB activity in hypoxic tumor cells
G-Y Jang et al.
ONCOGENE (2010)
Hypoxia-Inducible Factor-1 as a Therapeutic Target in Endometrial Cancer Management
Laura M. S. Seeber et al.
OBSTETRICS AND GYNECOLOGY INTERNATIONAL (2010)
The role of topoisomerase IIα and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients
Catherine Oakman et al.
CANCER TREATMENT REVIEWS (2009)
Role of Hypoxia in the Hallmarks of Human Cancer
Kai Ruan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target
Randy L. Jensen
JOURNAL OF NEURO-ONCOLOGY (2009)
Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1
Richard Sullivan et al.
MOLECULAR CANCER THERAPEUTICS (2009)
An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia
Yair Benita et al.
NUCLEIC ACIDS RESEARCH (2009)
Hypoxia-Induced Decrease in p53 Protein Level and Increase in c-jun DNA Binding Activity Results in Cancer Cell Resistance to Etoposide
Jean-Philippe Jp Cosse et al.
NEOPLASIA (2009)
Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression
Jean-Philippe Cosse et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
Hypoxia upregulates the histone demethylase JMJDIA via HIF-1
Sven Wellmann et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Hypoxia-Inducible Factor-2α Correlates to Distant Recurrence and Poor Outcome in Invasive Breast Cancer
Karolina Helczynska et al.
CANCER RESEARCH (2008)
An overview of cancer multidrug resistance: a still unsolved problem
H. Lage
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Targeting tumour hypoxia in breast cancer
Manuela Milani et al.
EUROPEAN JOURNAL OF CANCER (2008)
Heparin-binding EGF-like growth factor is induced by disruption of lipid rafts and oxidative stress in keratinocytes and participates in the epidermal response to cutaneous wounds
Conny Mathay et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity
Audrey Sermeus et al.
MOLECULAR CANCER (2008)
RPN2 gene confers docetaxel resistance in breast cancer
Kimi Honma et al.
NATURE MEDICINE (2008)
Evaluation of HIF-1 inhibitors as anticancer agents
Gregg L. Semenza
DRUG DISCOVERY TODAY (2007)
Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines
Jean-Philippe Cosse et al.
MOLECULAR CANCER (2007)
AffyProbeMiner: a web resource for computing or retrieving accurately redefined Affymetrix probe sets
Hongfang Liu et al.
BIOINFORMATICS (2007)
Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma
Xiong-Zhi Wu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Tissue transglutaminase-mediated chemoresistance in cancer cells
Amit Verma et al.
DRUG RESISTANCE UPDATES (2007)
Tumor hypoxia imaging with [F-18] fluoronitroimidazole in non-small-cell lung cancer
Hiroyasu Yasuda et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2007)
Transcriptional profiling of human cord blood CD133(+) and cultured bone marrow mesenchymal stem cells in response to hypoxia
Enca Martin-Rendon et al.
STEM CELLS (2007)
Hypoxia in cancer: significance and impact on clinical outcome
Peter Vaupel et al.
CANCER AND METASTASIS REVIEWS (2007)
Neurophysiological evaluation of healthy human anorectal sensation
M. L. Harris et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
James L. Tatum et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Why therapeutic response may not prolong the life of a cancer patient - Selection for oncogenic resistance
MV Blagosklonny
CELL CYCLE (2005)
The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation
B Bedogni et al.
CANCER CELL (2005)
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study
M Nordsmark et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Effects of the cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) on the physiology of cultured human keratinocytes
G Atanasova et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Array-based comparative gene expression analysis of tumor cells with increased apoptosis resistance after hypoxic selection
M Weinmann et al.
ONCOGENE (2005)
Tumoral drug metabolism: Overview and its implications for cancer therapy
M Michael et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers -: art. no. 27
H Cangul
BMC GENETICS (2004)
A model-based background adjustment for oligonucleotide expression arrays
ZJ Wu et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2004)
Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1α activation
O Minchenko et al.
FEBS LETTERS (2004)
The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c
NO Karpinich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene -: Its possible role in the Warburg effect
A Minchenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hypoxia induces the expression of the pro-apoptotic gene BNIP3
K Guo et al.
CELL DEATH AND DIFFERENTIATION (2001)
Share Paper
